loader from loading.io

In the News.. Dexcom G7 approved in Europe, people with diabetes living longer, non-profit insulin and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 03/18/2022

"You are raising fearless children" journalist Madison Carter speaks at Moms' Night Out Charlotte

Diabetes Connections | Type 1 Diabetes

This week, what growing up with diabetes meant for career choices, financial decisions, and family relationships. Madison Carter is a local news anchor who makes T1D very visible – and she does not hold back. She’s generous with incredible insight into how she was raised, sacrifices her family made and what her mom and dad have to say now. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from...

info_outline
“As active as I want to be” - Dianne Mattiace uses Eversense CGM to thrive with T1D in her 70s show art “As active as I want to be” - Dianne Mattiace uses Eversense CGM to thrive with T1D in her 70s

Diabetes Connections | Type 1 Diabetes

This week, managing type 1 diabetes into your 70s is a bit of uncharted waters.. While thankfully more and more people are living long with T1D, that wasn’t always the case. I’m taking to Dianne Mattiace who is in her early 70s and was diagnosed as an adult, 30 years ago. She was the first person in the US to use the Eversense CGM when it was approved in 2018 and she’s still using it today. She answers your questions about this implantable CGM, why she’s stayed with it and what else she does to manage in retirement and beyond.   This podcast is not intended as medical advice. If...

info_outline
In the News...  Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more! show art In the News... Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that's already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting oral meds, genetic T1D studies and more!  Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and...

info_outline
“How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean show art “How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean

Diabetes Connections | Type 1 Diabetes

This week, catching up with Medtronic’s Senior Director of Global Medical Affairs Dr. Jennifer McVean. It’s been one year since the 780G was approved in the US, what does the device – and its seven-day infusion set – look like in the real world. Plus, we have a big discussion about the future of type 1 diabetes – Dr. McVean has lead some significant trials – she lives with type 1 and has some big ideas about changes she’d like to see. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.   Find out...

info_outline
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin show art Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin

Diabetes Connections | Type 1 Diabetes

This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they’re called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It’s very ambitious and we have a wide ranging conversation about it all with Sequel’s CEO Alan Lotvin This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our...

info_outline
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more! show art In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT diabetes diagnosis and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show...

info_outline
The FDA took down this teen’s free bolus calculator. He needs your help to bring it back. show art The FDA took down this teen’s free bolus calculator. He needs your help to bring it back.

Diabetes Connections | Type 1 Diabetes

There used to be a lot of bolus calculators in the app store, maybe you’ve used one and haven’t updated it in a while. Don’t try now.. it’s likely been pulled. Apple and the FDA are cracking down on this types of tools – no unreasonable, right? But surely there are more coming.. how hard can it be to create a simple insulin bolus calculator that’s FDA approved, easy to find, easy to use, free, and doesn’t require you buy anything else? Turns out, it’s pretty darn hard. We’re talking about that today with the inventor of such an app with an interesting story – he’s still...

info_outline
Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder show art Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder

Diabetes Connections | Type 1 Diabetes

Diabetes technology is getting better and better. We have automated insulin systems that link pumps and CGMs, and smart insulin pens that have precise calculations and reminders. It’s been quite the evolution over the past few years! But outcomes – time in range, A1Cs, aren’t exactly where experts thought they might be. I’m talking to Dr. Stephen Ponder about why that is, how a social media post he shared about this caused a strong reaction, and what does work for better long term outcomes. This podcast is not intended as medical advice. If you have those kinds of questions, please...

info_outline
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more! show art In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and links below Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures Learn more about  Drive  The best way to keep up...

info_outline
Answering your questions about Tandem’s new Mobi pump (and more) with Director of Product Marketing Ben Mar show art Answering your questions about Tandem’s new Mobi pump (and more) with Director of Product Marketing Ben Mar

Diabetes Connections | Type 1 Diabetes

Approved last year, Tandem’s Mobi is now widely available. We’re getting an update from Ben Mar, Director of Product Marketing, on the features of the Mobi that make this tiny pump different and we look ahead to what Tandem is working on next. Ben also answers your questions about everything from algorithm updates, international access, and much more This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about ...

info_outline
 
More Episodes

It’s “In the News…” Got a few minutes? Get caught up! Top stories this week: Dexcom G7 approved in Europe, JDRF speaks out on non-profit insulin plan, Ukraine diabetes aid progress, texting for T2D, Reaction to Pixar's Turning Red
--
Join us LIVE every Wednesday at 4:30pm ET

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Episode Transcription Below (or coming soon!)

Please visit our Sponsors & Partners - they help make the show possible!

*Click here to learn more about OMNIPOD*

*Click here to learn more about DEXCOM*

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast.
XX
The news is brought to you by The World's Worst Diabetes Mom: Real Life Stories of Parenting a Child With Type 1 Diabetes. Winner of best new non-fiction at the American Book Fest and named a Book Authority best parenting book. Available in paperback, eBook or audio book at amazon.
XX
Our top story this week.. Dexcom gets the CE Mark for it’s new G7 system, which means it’s approved in Europe. The approval is for people ages 2 and up, including pregnant women. I’m putting the full screen photo up here and I’ll post this on the website and in the FB group for those listening.. interesting to finally get a good look at the much smaller applicator – as expected looks a lot like the Libre. Also interesting, all the PR for this has said, developed in partnership with Verily.. remember them? That was part of google, probably best known for saying they were going to develop a contact lens that would monitor glucose. I’ve reached out to Verily, love to know more about this partnership. Anyway, we’ve done a ton on G7, I’ll link up some of our recent conversations with the folks at Dexcom. They submitted to the US FDA at the end of 2021, no firm timeline on US approval.
https://www.medicaldevice-network.com/news/dexcom-ce-mark-g7-cgm-system/
XX
Some good news about living longer with chronic conditions, including diabetes. This was a 20-year British study that ended in 2011, so one caveat here, it doesn’t include COVID. Men gained 4-point-6 years of life expectancy; women gained 2-point-1. When it comes to disability-free life expectancy, men gained about a year less and women stayed the same. This included people with chronic conditions including those with diabetes. These researchers do point out that while they’d expect to see the same increase in the US – the lack of health and social safety net programs could make a negative difference here. But they point to CGM technology and better medication as making a big difference for those with diabetes.
https://www.healthline.com/health-news/why-people-with-chronic-conditions-such-as-diabetes-are-living-longer-without-disability#Cognitive-impairment-is-the-exception
XX
Children who develop type 1 diabetes show epi-genetic changes in the cells of their immune system long before the antibodies of the disease are detected in their blood. An epigenetic change affects how our genes work. Outside factors such as environmental, viral infections, are usually the cause. These researchers say these are previously unknown changes that signal the increased risk of developing type 1 and could give an even earlier indication than the anti-body marker tests available now.
https://www.news-medical.net/news/20220316/Epigenetic-changes-could-be-a-biomarker-for-early-detection-of-type-1-diabetes.aspx
XX
Could text-messaging with their doctors help people with type 2? A new team in Chicago is looking at text-based intervention in underserved communities. The intervention will deliver personalized information directly to patients through text messages, including reminders about self-monitoring and prescription refills, interactive office hours and general information about diabetes, motivational support and answers to frequently asked questions. These doctors say the idea is to create more opportunities for patients to meaningfully engage and reduce barriers by employing technology already in people’s hands.
https://today.uic.edu/an-sms-solution-for-type-2-diabetes
XX
Last week we told you about the effort by Civica RX to make affordable insulin. Civica, is a nonprofit generic pharmaceutical company. JDRF directed funds to this effort and CEO Aaron Kowalski wrote an op ed that I’ll link up. In it, he talks about the success Civica has had lowering the costs of other medications. We’ll have Kowalski on the show soon and I’ve reached out to Civica as well. This would lower the price to $35 a vial no matter your insurance. Congress still hung on a $35 co-pay cap for those with insurance.
https://www.healthline.com/diabetesmine/op-ed-jdrf-leader-on-insulin-affordability-for-all-americans
XX
Over in the UK they keep moving forward – covering all 400-thousand Britons with type 1 for the Libre CGM. Former guest of the podcast, Dr. Partha Kar, says everyone with type 1 will be able to get a CGM if they want one by the end of March. It will no longer be restricted by who doctors think need it the most. By the way, Briton means someone from England, Scotland or Wales. It’s the first time I’m using that word so UK friends.. let me know if I’ve got it right!
https://www.dailymail.co.uk/health/article-10606335/All-400-000-type-1-diabetic-Britons-offered-high-tech-implant.html
XX
Still a big need for diabetes help to Ukraine. A lot of the efforts are paying off – Insulin for Life showing that the supplies are on their way or have arrived. Spare a Rose reports that individual donations so far have totaled more than 115-thousand-dollars. I’ll keep linking up places to donate
https://www.jdrf.org/blog/2022/03/02/helping-the-diabetes-community-in-ukraine/
XX
Reaction to Pixar’s Turning Red. I loved this. I put out a call for photos of people seeing themselves in the movie’s tiny little moments of diabetes representation. Thanks to all who sent those in – you can see them on Diabetes Connections on Facebook and Twitter. And my Stacey Simms account on Instagram. It’s all just one account there.
XX
While Turning Red had diabetes in the background.. this week on the long format episode we’re talking about a movie that wants to put type 1 front and center. And it’s got the Star Trek community excited as well! Meet the Star Trek Discovery actor with type 1 who’s leading this effort.
Next week, we’re going on a deep dive about stem cell research with the folks at Viactye. They’re working on two fronts now.. encapsulation AND gene editing with the people at CRISPR.
Listen wherever you get your podcasts
That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.